Format

Send to:

Choose Destination
See comment in PubMed Commons below
Infect Drug Resist. 2011;4:115-27. doi: 10.2147/IDR.S13808. Epub 2011 May 24.

Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin.

Author information

  • 1Brownlee Center, Gartnavel General Hospital, Glasgow, Scotland.

Abstract

Skin and soft tissue infections (SSTIs) are the second most common infection encountered in hospitals. Management decisions have become increasingly complex due to the prevalence of resistant pathogens, the wide array of licensed antimicrobials and the availability of potent oral agents and of out-patient parenteral antibiotic therapy. Daptomycin is one of the newer therapeutic agents licensed for complex SSTI management. Rapid cidality, good soft tissue penetration, once daily IV bolus administration and activity against resistant Gram-positive infections make daptomycin an attractive option both in hospitalized and community treated patients. A comprehensive review of the evidence for and experience with daptomycin and its use in SSTIs is presented.

KEYWORDS:

MRSA; OPAT; SSTI; lipopeptide; outpatient parenteral antibiotic therapy

PMID:
21753891
[PubMed]
PMCID:
PMC3132872
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk